Members and Friends,
JPM 2020 is Here! Just five years ago, Virginia Bio held its first Virginia Reception at the San Francisco Clift Hotel’s Velvet Room during the 33rd Annual J.P. Morgan Healthcare Conference. Given its incredible success and impact upon our members, we have every year since continued the tradition, and we are proud to bring the Virginia Reception back to the Velvet Room on Sunday, January 12 for JPM 2020. The 38th J.P. Morgan Healthcare Conference will be held January 13-20, 2020 at the Westin St. Francis in San Francisco and is the largest healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. Attendees come from the entire global healthcare landscape, including pharmaceutical companies, healthcare service providers, profit and not-for-profits, and medical device companies. The Virginia Reception will be the kick-off to a great week, and has historically seen over 200 friends gather to share the story of Virginia’s biotechnology ecosystem and connect our members to the investor community. Connections made that evening and elsewhere roll into the following three days in reserved meeting spaces in the Clift Hotel provided by Virginia Bio, on a pre-reserved basis and at no cost to our members. Attendance at JPM 2020 is limited (and hotel rooms even more so!), so please be sure to mark your calendars, make your hotel reservations, and be on the lookout for more information from Virginia Bio regarding the Virginia Reception!
Virginia Bio Advocacy for the Industry: We have recently lent the voice of Virginia Bio to two very important issues affecting many of our members.
Permanent Repeal of the Medical Device Tax. Continuing an effort led by the Medical Device Manufacturers Association (MDMA) 2009, Virginia Bio joined MDMA and 615 other life science organizations and companies, including the Advanced Medical Technology Association (AdvaMed) and the Medical Imaging & Technology Alliance (MITA), on a September 24 letter to Congressional leaders urging a permanent repeal of the medical device tax. The 2.3% tax, imposed upon medical devices in 2013 and suspended in 2015, will be reimposed January 1, 2020 if not repealed. The adverse impact on R&D investment and job creation would jeopardize the U.S.’s position as a global leader in medical device innovation, and it is estimated that a reinstatement of the tax could result in the loss of 21,000 jobs. You can see the letter here.
Drug Pricing: Comments Submitted to the Virginia Joint Commission on Healthcare; Letter to Congress from 44 Trade Associations Opposing International Price Referencing. On September 25, Virginia Bio submitted comments on several policy proposals being considered by the Virginia General Assembly to, among other things: implement Virginia state government drug affordability Board and upper pay limits, ban pay-to-delay agreements, and develop a program to import drugs from Canada. Our comments opposing these ideas align with those submitted by BIO and PhRMA. You can see our letter here. Relatedly, Virginia Bio joined an October 16 letter, addressed to Congress and joined by 44 state and regional life sciences and biotechnology associations, opposing international price referencing or other price controls. You can see that letter here.
Upcoming Events. We look forward to seeing you at our next Virginia Bioscience Commercialization Luncheon in Richmond, November 14, featuring Donna Edmonds, CEO of BRAINBox Solutions, Inc. Donna will be discussing BRAINBox’s innovative biomarker panels, as well as neurocognitive testing, which provide objective evidence of traumatic brain injury and prediction of patient recovery. Join us to hear about her journey as a serial entrepreneur and CEO, her experience raising capital, and how she and her team are innovating a new generation of concussion testing.
As you are also viewing other events on our calendar, we call special attention to the Southeast BIO Investor & Partnering Forum (SEBIO), November 6-7 at the Biltmore Hotel in Miami/Coral Gables, Florida. SEBIO is the region’s leading life sciences and medical technology conference, connecting emerging companies with potential investors and corporate partners. Celebrating its 21st anniversary, the SEBIO Investor & Partnering Forum will feature new networking opportunities and expanded investment prospects.
Your Ideas. Virginia Bio wants to hear from you! My visits with our members and partners during these first few weeks have been enlightening and motivating! Please do not wait for the occasion of my visit with you to provide feedback; send us your ideas, comments, suggestions and advice regarding how Virginia Bio can best support you and our biotechnology ecosystem. Contact us at firstname.lastname@example.org.